摘要
目的:分析冠状动脉CTA和DSA对冠心病患者临床诊断价值。方法:选取2020年1月~2022年6月在天津医科大学朱宪彝纪念医院接受治疗的64例冠心病患者为研究对象,分别对其进行CTA和DSA检查。选取具有资深诊断经验的同一批诊断医师对CTA和DSA检测结果进行分析诊断,并将诊断结果分别记为观察组和对照组。观察CTA和DSA两种检测方式冠状动脉血管狭窄、斑块性质情况及CTA对冠状动脉血管狭窄诊断价值。结果:以DSA检测结果为诊断金标准,CTA狭窄血管检出率为98.51%。两组检测结果之间在血管狭窄类型以及斑块性质方面差异无统计学意义(P>0.05)。CTA检测灵敏度为98.33%(118/120),CTA检测特异度为95.39%(269/282)。结论:冠状动脉CTA和DSA对冠心病患者均具有较高的诊断价值,冠状动脉CTA为无创操作。
Objective:To analyze the clinical diagnostic value of coronary CTA and DSA in patients with coronary heart disease.Methods:From January 2020 to June 2022,64 patients with coronary heart disease were selected from the Tianjin Medical University Chu Hsien-I Memorial Hospital and underwent CTA and DSA examinations.The same group of experienced doctors were selected to analyze the results of CTA and DSA,and the results were recorded as observation group and control group respectively.To observe the stenosis and plaque character of coronary artery by CTA and DSA and the diagnostic value of CTA in coronary artery stenosis.Results:Using DSA detection results as the diagnostic gold standard,the detection rate of CTA stenosis in blood vessels was 98.51%.There was no statistically significant difference(P>0.05)between the two test results in terms of vascular stenosis type and plaque properties.The sensitivity and specificity of CTA were 98.33%(118/120)and 95.39%(269/282)respectively.Conclusion:Both coronary CTA and DSA have high diagnostic value in patients with coronary heart disease.Coronary CTA is a non-invasive procedure.
作者
张昕
ZHANG Xin(NHC Key Laboratory of Hormones and Development(Tianjin Medical University),Tianjin Key Laboratory of Metabolic Diseases,Tianjin Medical University Chu Hsien-I Memorial Hospital&Tianjin Institute of Endocrinology,Tianjin 300134)
出处
《中国医疗器械信息》
2024年第2期4-6,共3页
China Medical Device Information